When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALXN - Alexion's sBLA for Ultomiris gets priority review
Alexion Pharmaceuticals Inc.
The FDA accepts for priority review Alexion's (NASDAQ:ALXN) supplemental Biologics License Application for Ultomiris (ravulizumab-cwvz) for the treatment of atypical hemolytic uremic syndrome to inhibit complement-mediated thrombotic microangiopathy.
More news on: Alexion Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,